CD48 and Miyoshi myopathy: In these analyses, the MM patients exhibited a significantly lower NK cell production of granzyme B and IFN-γ than the HD subjects, which was a more prominent difference when using P815-ULBP1+CD48 target cells compared with the other target cells.